Response Of Arteriovenous Fistula Puncture-related Pain To Cryotherapy Application In Haemodialysis Patients
1 other identifier
interventional
90
1 country
1
Brief Summary
Kidney disease occurs when kidney reduces its normal function, less than 30% of normal activity is related to a long-term condition. Therefore, people need to participate in a haemodialysis (HD) programme. In HD, blood is filtered by an external machine, done about three times a week and the access is gained through intermittent vascular cannulation. The patients experience considerable pain due to the frequent insertion of AVF catheters. Hemodialysis patients experience anxiety before needle insertion due to repeated punctures, and over 90% of patients experience acute pain during the process. Puncture-related pain during arteriovenous fistula (AVF) cannulation in particular is a crucial influential factor in quality of life. Cryotherapy is one of the interventions used in several studies to alleviate the arteriovenous fistula puncture-related pain. It can be conduct by using ice packs and the results of the previous studies have also shown its positive effects on the relief of the fistula puncture-related pain in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2024
CompletedFirst Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedAugust 6, 2024
August 1, 2024
4 months
July 10, 2024
August 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Visual analogue scale (VAS):
Scale to measure the intensity of pain The minimum value is 0 which means no pain and the maximum value is 10 which means the maximum pain
Visual analogue scale measured at baseline, and it will be measured again immediately after 20 sessions
Secondary Outcomes (2)
The Arm Motor Ability Test (AMAT)
The Arm Motor Ability Test (AMAT): it is measured at baseline, and it will be measured again immediately after 20 sessions.
Hospital Anxiety and Depression Scale (HADS):
Hospital Anxiety and Depression Scale (HADS): it is measured at baseline, and it will be measured again immediately after 20 sessions.
Study Arms (2)
Cryotherapy to arteriovenous fistula puncture site
ACTIVE COMPARATORThis group of patients receives ice pack applied on the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis.
Cryotherapy to site opposite to arteriovenous fistula puncture site
ACTIVE COMPARATORThis group of patients receives ice pack applied on contralateral to the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis.
Interventions
One group of patients receives ice pack applied on the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis. The second group of patients receives ice pack applied on contralateral to the site of the cannulation, for 20 sessions (3 sessions per week) it introduced for 5-10 minutes before the beginning of the dialysis.
Eligibility Criteria
You may qualify if:
- The study includes patients with ages from 30 to 50 years.
- Patients able to report pain adequately.
- Patients with end-stage kidney failure undergoing regular hemodialysis who have been treated for more than 3 months, at least twice per week, with arteriovenous fistula in use for more than 1 month are included in the study.
You may not qualify if:
- Patients with conditions such as
- advanced age,
- advanced diabetes,
- cardiovascular insufficiency,
- cold allergy,
- Reynaud's phenomenon,
- nerve and tissue damage,
- fractures,
- heart failure,
- uncooperative patients,
- cognitive impairment preventing a proper assessment of pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo university
Cairo, 11432, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nagwa Mohamed Badr, Professor
Cairo University
- STUDY DIRECTOR
Sahier Omar El-khashab, Professor
Cairo university El-kasr el-aini
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical therapist
Study Record Dates
First Submitted
July 10, 2024
First Posted
July 25, 2024
Study Start
May 4, 2024
Primary Completion
August 24, 2024
Study Completion
August 31, 2024
Last Updated
August 6, 2024
Record last verified: 2024-08